Topical Emulgel: Combining Emulsion and Gel for Improved Drug Delivery Efficiency

Abstract

Topical emulgel combines the unique advantages of emulsions and gels to create an advanced drug delivery system with improved efficiency. Emulgels are formulated by dispersing drug-incorporated emulsion droplets into a gel base, resulting in a dosage form that offers dual controlled release. This hybrid system enhances the delivery of both hydrophobic and hydrophilic drugs, overcoming limitations seen in conventional gels, especially for poorly water-soluble drugs. The gel base provides a non-greasy, smooth, and easily spreadable texture that favors patient compliance, while the emulsion phase improves drug entrapment and release kinetics. Emulgels exhibit suitable pH for skin application, minimize skin irritation, and provide sustained drug release, typically following zero-order kinetics and diffusion mechanisms. The formulation stability, adhesiveness, and cosmetic acceptability make emulgels ideal for topical treatment of inflammatory, analgesic, antifungal, and acne-related conditions. Overall, emulgels represent a promising topical drug delivery platform with enhanced bioavailability, penetration, and patient adherence compared to traditional creams or gels, making them valuable in pharmaceutical and cosmetic applications.

Keywords

Introduction

Topical drug delivery systems enable the direct application of therapeutic agents onto the skin surface, providing localized treatment with minimal systemic absorption and side effects. Such systems are extensively used for dermatological conditions like inflammation, infections, and pain management. However, conventional topical formulations, including creams, ointments, and gels, often exhibit limitations such as poor drug solubility, low bioavailability, inconvenient greasiness, and inadequate spreadability, which may reduce patient compliance and therapeutic effectiveness. To overcome these challenges, emulgel formulations have emerged as a novel and promising approach. Emulgels are hybrid systems where drug-loaded emulsions (either oil-in-water or water-in-oil) are incorporated into a gel matrix - combining the solubilizing advantages of emulsions with the ease of application and non-greasy nature of gels. This dual-phase system provides superior topical delivery by enhancing drug solubility, improving release kinetics, and maintaining stability.

The gel base contributes a smooth, non-greasy, and easily spreadable texture that promotes patient adherence and aesthetic acceptance. Meanwhile, the emulsion phase allows efficient incorporation of hydrophobic drugs, overcoming the limitations faced by conventional gels in delivering poorly water-soluble compounds. The pH of emulgel formulations is typically compatible with that of human skin, reducing irritation risk. Moreover, emulgels often display sustained or controlled drug release profiles governed primarily by diffusion mechanisms, allowing prolonged therapeutic effects and reduced application frequency.

Developing a stable and effective emulgel requires careful selection of gelling agents, emulsifiers, oil phase, and penetration enhancers. These components influence the rheology, adhesiveness, spreadability, and drug release behaviors of the formulation. Techniques such as nano- or micronization of emulsion droplets further enhance stability and bioavailability. Incorporation of penetration enhancers can improve drug permeation through the skin barrier, as demonstrated through ex vivo studies. Emulgels have been successfully formulated for a wide range of topical drugs, including anti-inflammatory agents (e.g., diclofenac), analgesics, antifungal compounds, and anti-acne medications. Clinical and experimental evidence supports their advantages over traditional creams or gels in terms of enhanced drug delivery efficiency, reduced skin irritation, and improved patient compliance.

Emulgels signify a cutting-edge advancement in topical drug delivery technology, combining the beneficial characteristics of emulsions and gels. This integration enables improved solubilization, controlled release, and superior topical bioavailability of both hydrophilic and hydrophobic drugs. Continued research into formulation optimization, novel excipients, and clinical applications is likely to further establish emulgels as an important and versatile platform in pharmaceutical and cosmetic dermatology.

Types and Preparation Methods of Emulgel

Emulgels are innovative topical drug delivery systems that combine the advantages of emulsions and gels, allowing enhanced delivery of both hydrophilic and hydrophobic drugs. Their unique dual-phase nature improves drug solubility, stability, controlled release, and patient compliance. Emulgels are broadly classified based on the type of emulsion used and the droplet size within the formulation. The choice of preparation method significantly influences the physicochemical properties and therapeutic efficacy.

Types of Emulgel

Based on Emulsion Type

• Oil-in-Water (O/W) Emulgel: The oil phase is dispersed in a continuous aqueous phase. This type is commonly used to deliver lipophilic drugs due to better patient acceptability and less greasiness.
• Water-in-Oil (W/O) Emulgel: Water droplets are dispersed in an oil continuous phase. W/O emulgels are preferred for hydrophilic drugs, offering enhanced skin occlusiveness.

Based on Droplet Size

• Macroemulsion Gel: Droplet size exceeds 400 nm, resulting in an opaque system. These emulsions are thermodynamically unstable but can be stabilized using surfactants. Macroemulsions are the most common type of emulgels.
• Nanoemulgel: Incorporates nanoemulsions with droplet sizes from 1 nm to 100 nm. Nanoemulgels exhibit enhanced transdermal permeation and stability and deliver drugs more efficiently due to small globule size.
• Microemulsion Gel: Microemulsions are thermodynamically stable, optically transparent mixtures with droplet sizes between 10-100 nm. Due to low viscosity, microemulsions are gelled with agents like Carbopol or HPMC to improve topical application.

Preparation Methods of Emulgel

Emulgel formulation generally involves three main steps:

Step 1: Preparation of Gel Base

A suitable gelling agent (e.g., Carbopol 940, HPMC, Guar gum) is dissolved in distilled water with continuous stirring to form a homogeneous gel. The pH is adjusted between 5-6.5 using neutralizing agents such as triethanolamine or NaOH. Commonly used gelling agents and their concentrations include Carbopol 940 (0.75-2%), HPMC (4-6%), and Guar gum (0.5%).

Step 2: Formation of Emulsion

Depending on the intended type of emulsion (O/W or W/O), the aqueous and oil phases are prepared separately. Surfactants and co-surfactants are used to stabilize the emulsion. Typically, the oil phase (containing oil and lipophilic drug) is slowly added dropwise to the aqueous phase (or vice versa) under constant stirring or homogenization. Mixing continues until a stable emulsion with desired droplet size is achieved. For nanoemulsions or microemulsions, specialized high-energy methods or specific surfactant/co-surfactant ratios are used to obtain small droplet sizes.

Step 3: Incorporation of Emulsion into Gel Base

The prepared emulsion is gradually mixed into the gel base with gentle stirring or homogenization to form a uniform emulgel. Homogenization ensures even distribution of emulsion droplets within the gel matrix, providing stability and desired viscosity.

The design and manufacturing of emulgels require attention to formulation parameters that influence stability, drug release, and skin permeation. Utilizing appropriate gelling agents, surfactants, and preparation techniques allows the development of efficient emulgel systems tailored for specific therapeutic needs.

Evaluation Tests:

1. Physical Appearance and Homogeneity

Visual inspection is performed to check the color, texture, consistency, and homogeneity of the emulgel. A well-prepared emulgel should have a smooth, uniform, white to off-white appearance without any phase separation, lumps, or grittiness. This evaluation helps detect physical stability issues early.

2. pH Determination

The pH of the emulgel is measured using a digital pH meter to ensure compatibility with skin pH (generally around 5.5 to 6.5). Maintaining a suitable pH prevents skin irritation and preserves the formulation's stability.

3. Drug Content Uniformity

Drug content is analyzed by accurately weighing a specific quantity of emulgel, dissolving it in an appropriate solvent, filtering, and measuring absorbance via UV-spectrophotometry. This test confirms the uniform distribution of the drug throughout the formulation. Ideal drug content values range from 95% to 105% of the labeled amount.

4. Spreadability

Spreadability indicates how easily the emulgel spreads on the skin, affecting patient compliance and dose uniformity. It is measured by applying a fixed amount of emulgel between two glass slides and measuring the time taken to separate or the area covered under a specific weight. Higher spreadability values indicate better ease of application.

5. Viscosity and Rheological Properties

Viscosity is assessed using a Brookfield viscometer or rheometer, providing insights into the flow behavior. A balance is needed: viscosity should be high enough to maintain the gel structure yet low enough for smooth application. Rheological studies help understand thixotropic and shear-thinning properties relevant for topical use.

6. Globule Size and Distribution

The size of emulsion droplets dispersed in the gel is determined using particle size analyzers such as Malvern zeta sizer. Smaller and uniformly distributed droplets ensure enhanced stability and better drug release.

7. In Vitro Drug Release Studies

These studies assess the rate and extent of drug release from the emulgel using dialysis membrane diffusion cells or Franz diffusion cells. The cumulative amount of drug released into a receptor medium over time is quantified spectrophotometrically, revealing release kinetics and predicting therapeutic efficacy.

8. Ex Vivo Skin Permeation Studies

Using animal or human excised skin mounted on Franz diffusion cells, drug permeation through the skin is measured. This test evaluates the bioavailability and penetration efficiency of the emulgel, typically demonstrating enhanced permeation compared to gel or cream formulations.

9. Skin Irritation Test

Conducted on animal models such as Wistar rats or rabbits, this patch test examines the potential of the emulgel to cause redness, swelling, or other adverse skin reactions after topical application. A non-irritant formulation is critical for patient safety and compliance.

10. Stability Studies

Emulgels are subjected to stability testing under various temperature and humidity conditions for weeks to months to monitor changes in physical appearance, pH, viscosity, drug content, and drug release. Stability testing ensures the formulation maintains quality during storage without phase separation or degradation.

11. Additional Characterizations

• Fourier Transform Infrared Spectroscopy (FTIR): Used to detect any chemical interactions between the drug and excipients to ensure compatibility.
• Centrifugation Test: Helps assess physical stability by accelerating phase separation under stress. No separation indicates good stability.
• Swelling Index: The ability of the emulgel to absorb water and swell is measured, which influences drug release and skin adhesion.

Each of these evaluation tests collectively confirms that the emulgel is physically stable, chemically compatible, safe for topical application, and efficacious in delivering the drug through the skin with optimal release and permeation profiles.

Advantages of Emulgel

• Incorporation of Hydrophobic Drugs: Emulgels can effectively incorporate hydrophobic drugs by solubilizing them in the oil phase of the emulsion, overcoming a major limitation of conventional gels.
• Improved Stability and Loading Capacity: Compared to creams and ointments, emulgels exhibit better physical stability, avoiding issues like phase separation, rancidity, and poor shelf life. The gel's polymeric network also allows better loading and entrapment of drugs than vesicular systems like liposomes and niosomes.
• Controlled and Sustained Drug Release: Emulgels provide dual controlled release mechanisms from both emulsion and gel phases, resulting in prolonged therapeutic effects and reduced dosing frequency.
• Non-Greasy, Easy Spreadability: Their non-greasy texture and good spreadability improve patient compliance and make topical application more pleasant compared to ointments or creams.
• Avoidance of Sonication: Unlike vesicular systems, emulgels do not require intensive sonication that can cause drug degradation or leakage, simplifying manufacturing.
• Targeted Delivery and Avoidance of First-Pass Metabolism: As topical systems, emulgels can deliver drugs directly to the site of action and bypass hepatic first-pass metabolism.
• Cost-effective and Easy Production: The preparation of emulgels involves simple, low-cost steps without the need for specialized instruments, making production feasible at scale.

Disadvantages of Emulgel

• Skin Irritation and Allergic Reactions: Some drugs or excipients in emulgels may cause irritation or allergic contact dermatitis in sensitive individuals.
• Poor Permeability for Some Drugs: The skin’s complex barrier limits the penetration of certain drugs, particularly those with large molecular size or poor skin permeability, restricting the utility of emulgels for all drug types.
• Bubble Formation During Preparation: Entrapped air bubbles can occur in emulgels during formulation, which may affect appearance and texture, though this can sometimes be minimized by careful mixing or sonication.
• Limited to Hydrophobic Drugs Mainly: Although emulgels are effective for hydrophobic drugs, their advantages may be less significant for highly hydrophilic drugs that may not benefit from the emulsion phase.
• Large Particle Size Drugs: Drugs with large particle sizes do not easily absorb through the skin from emulgels, limiting the range of suitable drugs.

CONCLUSION:

In conclusion, emulgels represent an advanced and versatile topical drug delivery system that effectively merges the benefits of emulsions and gels to overcome the limitations commonly associated with conventional topical formulations. Their unique dual-phase structure enables efficient incorporation and sustained release of both hydrophobic and hydrophilic drugs, enhancing therapeutic efficacy and patient compliance. The simple and cost-effective preparation methods, coupled with favorable properties such as non-greasiness, good spreadability, and skin compatibility, make emulgels an attractive choice for topical applications across various therapeutic areas.

However, despite these numerous advantages, certain challenges remain, such as the potential for skin irritation in some individuals and limitations in permeating drugs with large molecular sizes or poor skin permeability. Formulation optimization, including selection of appropriate gelling agents and penetration enhancers, is essential to maximize stability, efficacy, and safety. Evaluation tests including physical characterization, drug release, skin permeation, and stability studies are critical to ensuring quality and performance.

Overall, emulgels hold great promise for improving topical drug delivery efficiency and expanding the scope of dermatological and transdermal therapies. Continued research and development efforts are likely to further enhance their applicability and overcome existing limitations, reinforcing their role as a convenient, patient-friendly, and effective drug delivery platform.

REFERENCES

1. Jabbar MJ. An overview of emulgels for topical application. Asian Journal of Pharmaceutical Sciences. 2023 Jul 19
2. Waghmare ND. Emulgel: A novel topical drug delivery system. Asian Journal of Pharmaceutical Research and Development. 2025 Apr 14;13(2):82–91.
3. Lilhare KT. Recent update on topical drug delivery systems: Emulgel. Asian Journal of Pharmaceutical Research and Development. 2023;11(4):133–8.
4. Yadav SK, Mishra MK, Tiwari A, Shukla A. Emulgel: A new approach for enhanced topical drug delivery. International Journal of Current Pharmaceutical Research. 2016 Dec;9(1):15–9.
5. Milutinov J, Stanojkovic D, Nedeljkovic N. Emulgels: Promising carrier systems for topical drug delivery. Pharmaceutics. 2023;15(2):378.
6. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharmaceutical Journal. 2012 Jan;20(1):63–7.
7. Patel BM, Patel J, Rathod DA. Emulgel approach to formulation development: A review. Biotechnology: An Indian Journal. 2021;18(3):101–10.
8. Inamdar SN, Nirmal S, Landge D, Manmode P. Formulation and evaluation of pharmaceutical emulgel with indomethacin and Azadirachta indica for enhanced analgesic and anti-inflammatory effects. Journal of Neonatal Surgery. 2025 Jun 24
9. Kushwah P, Thakur S, Ghosh SN. Microemulgel: A novel approach for topical drug delivery. Journal of Advanced Pharmaceutical Technology & Research. 2021 Sep 29;12(4):383–91.
10. Patel R, Vora A, Rupenthal ID. Development and evaluation of nanoemulgel for the topical delivery of fluconazole. Drug Development and Industrial Pharmacy. 2019 Jun;45(6):917–26.
11. Jain A. A cutting edge approach for topical drug delivery system. Bentham Science Publishers. 2012.
12. Sharma D, Garg G, Singh H, Murthy RS. Formulation and evaluation of topical emulgel containing diclofenac sodium. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6(3):306-9.
13. Tiwari S, Tiwari G. Emulgel formulation: An advance topical drug delivery system. Journal of Drug Delivery Therapeutics. 2018;8(6-s):60–5.
14. Kumar D, Khullar R, Seth A, Saini S. Formulation and evaluation of anti-inflammatory emulgel containing ibuprofen. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(3):532–6.
15. Gupta S, Singh S, Kaur R. Emulgel: a promising vehicle for topical drug delivery systems. Journal of Pharmacy Research. 2014;8(9):1183–9.